The ACR, SAA, and SPARTAN released an updated guideline for the management of AS and axial SpA that provides an overview of new treatment options and the use of imaging.
Since ankylosing spondylitis can impact individuals who are of working age, researchers sought to determine the disease’s impact on overall work stability.
Researchers analyzed whether C-reactive protein level can be used to predict how a patient with ankylosing spondylitis will react to tumor necrosis factor-α blocker treatment.
To allow heath care providers to make the most informed treatment decisions for ankylosing spondylitis, researchers evaluated the efficacy and safety of long-term use of secukinumab.
HLA-B*27 positivity is related to two of the most hypomethylated loci in ankylosing spondylitis (AS), according to results of a new study presented at the 2018 ACR/ARHP Annual...
The ACR and the AAHKS have released new guidelines on the management of antirheumatic medications in patients with rheumatic disease undergoing elective total knee or hip arthroplasty.